UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date
of Report (Date of earliest event reported):
February 9, 2007
PROXYMED, INC.
(Exact name of registrant as specified in its charter)
| |
|
|
|
|
Florida
(State or other jurisdiction
of
incorporation)
|
|
000-22052
(Commission File No.)
|
|
65-0202059
(IRS Employer
Identification No.) |
1854 Shackleford Court, Suite 200,
Norcross, Georgia 30093-2924
(Address of principal executive offices)
(770) 806-9918
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions (see General Instruction
A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of
Certain Officers; Compensatory Arrangements of Certain Officers.
(b) On February 14, 2007, ProxyMed, Inc. d/b/a MedAvant Healthcare Solutions (“MedAvant”) issued a
press release to announce that James B. Hudak had been appointed as Chairman of the Board of
Directors (the “Board”) at a meeting of the Board held February 9, 2007.
A copy of MedAvant’s press release is attached as Exhibit 99.1.
Item 9.01 Financial Statements and Exhibit.
(d) Exhibits
| |
|
|
| Exhibit No. |
|
Description |
99.1
|
|
Press release of MedAvant dated February 14, 2007. |